Journey Medical Corporation DERM Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 65.4%-1.0pp | 66.2%+3.4pp | 70.2%+6.3pp | 69.4%-2.2pp | 66.5%-4.4pp | |
| Operating margin | -9.8%— | -13.2%— | —— | —— | —— | |
| Net margin | -14.8%— | -18.5%— | —— | —— | —— | |
| EBITDA margin | -3.1%— | -6.3%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | -36.6%— | -44%— | —— | —— | —— | |
| Return on assets | -10.9%— | -13.1%— | —— | —— | —— | |
| Return on invested capital | -23.2%— | -28.2%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.7×0.0× | 0.8×-0.1× | 0.8×-0.4× | 0.7×-0.2× | |
| Inventory turnover | 2.1×+0.4× | 1.7×0.0× | 1.5×-0.3× | 1.5×-0.5× | 1.6×-0.3× | |
| Liquidity | ||||||
| Current ratio | 1.7×+0.4× | 1.8×+0.4× | 1.4×0.0× | 1.3×-0.1× | 1.3×+0.1× | |
| Quick ratio | 1.5×+0.4× | 1.5×+0.6× | 1.1×+0.1× | 0.9×-0.1× | 1×+0.1× | |
| Cash ratio | 0.7×+0.2× | 0.6×+0.1× | 0.6×0.0× | 0.5×-0.2× | 0.5×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×-0.3× | 0.8×-0.5× | 1×-0.8× | 1.3×-0.4× | 1.2×0.0× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×+0.1× | |
| Interest coverage | -1.7×— | -2.2×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $1.13+18.5% | $1.30+32.4% | $1.04+95.0% | $0.83+46.3% | $0.95+45.3% | |
| Valuation | ||||||
| Market capitalization | $194.94M+20.9% | $209.22M+156% | $187.33M+65.8% | $148.63M+33.4% | $136.32M+91.7% | |
| Enterprise value | $193.19M+16.2% | $210.52M+144% | $187.68M+70.1% | $153.61M+43.1% | $140.41M+127% | |
| Price / sales | 3×+0.2× | 3.4×+1.9× | 3.2×+1.2× | 2.6×+1.2× | 2.4×+1.5× | |
| Price / book | 6.3×-2.1× | 6.6×+2.5× | 7.2×-3.1× | 7.7×-2.1× | 6.3×+0.8× | |
| EV / sales | 3×0.0× | 3.4×+1.9× | 3.2×+1.2× | 2.7×+1.3× | 2.5×+1.7× | |
| Earnings yield | -4.9%— | -5.5%— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Journey Medical Corporation's profit margins?
- Journey Medical Corporation (DERM) runs a 65.4% gross margin and a -9.8% operating margin, with a -14.8% net margin.
- Where do Journey Medical Corporation's ratios come from?
- Every ratio is computed from Journey Medical Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
